Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yoav Barnavon

Plastic Surgery Hollywood, FL Medical Doctor

NPI 1114972692 CMS profile 322425

1201 N 35Th Ave, Suite 200, Hollywood, FL 33021

Open in the dashboard

General payments

$23,877

273 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yoav Barnavon of Hollywood, FL is reported in the CMS Open Payments database as having received $23,877 across 273 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,420 65
2024 General $2,571 37
2023 General $2,468 37
2022 General $4,285 39
2021 General $1,928 39
2020 General $1,082 20
2019 General $2,122 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yoav Barnavon
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Yoav Barnavon were reported at $9,420. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Yoav Barnavon Plastic Surgery median Middle half National median
2019 $2,122 $371 $122–$1,483 $163
2020 $1,082 $158 $52–$438 $114
2021 $1,928 $249 $87–$752 $132
2022 $4,285 $274 $102–$793 $149
2023 $2,468 $299 $113–$891 $160
2024 $2,571 $361 $124–$1,062 $164
2025 $9,420 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Motiva USA, LLC $5,164 23 payments
  2. Mentor Worldwide LLC $2,466 35 payments
  3. TELA Bio, Inc. $2,267 46 payments
  4. Surgical Innovation Associates, Inc. $2,147 2 payments
  5. Bimini Technologies LLC $1,500 1 payment
  6. Musculoskeletal Transplant Foundation Inc. $1,214 13 payments
  7. Davol Inc. $1,202 13 payments
  8. Allergan Inc. $901 19 payments
  9. Integra LifeSciences Corporation $780 15 payments
  10. AbbVie, Inc. $600 15 payments
  11. Other $5,638 91 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,983 265 payments
  2. Consulting Fee $3,845 2 payments
  3. Honoraria $1,500 1 payment
  4. Travel and Lodging $809 2 payments
  5. Long term medical supply or device loan $647 1 payment
  6. Gift $87 1 payment
  7. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. Motiva Implant Matrix $5,043 20 payments
  2. DuraSorb Monofilament Mesh $2,147 2 payments
  3. MENTOR MemoryGel Resterilizable Gel Sizer $1,888 25 payments
  4. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $1,581 32 payments
  5. Phasix Mesh $536 4 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $492 10 payments
  7. NATRELLE $479 10 payments
  8. GalaFLEX $471 4 payments
  9. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $448 10 payments
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $422 9 payments
  11. Other $10,649 222 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

213

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$1,306

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

6.1%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Scopolamine Generic 32 $418
Ketorolac Tromethamine Generic 16 $255
Cephalexin Generic 57 $248
Gabapentin Generic 56 $185
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $85
Ciprofloxacin Hcl Generic 11 $61
Tramadol Hcl Generic 28 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$56,070

Medicare's payments for the services billed

Medicare patients

65

Average age 73

Services billed

243

49 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 72%
High blood pressure 63%
Arthritis 38%
Diabetes 31%
Ischemic heart disease 26%
Chronic kidney disease 25%
Depression 20%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record